Back to Journals » Journal of Vascular Diagnostics and Interventions » Volume 7

ClariVein®, mechanochemical endovenous ablation: patient selection and perspective

Authors Belramman A, Bootun R, Onida S, Davies AH, Lane TRA

Received 17 November 2018

Accepted for publication 31 July 2019

Published 2 September 2019 Volume 2019:7 Pages 1—8

DOI https://doi.org/10.2147/JVD.S167491

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 3

Editor who approved publication: Dr Deipolyi


Amjad Belramman,1 Roshan Bootun,1,2 Sarah Onida,1,3 Alun H Davies,1,3 Tristan RA Lane1,3

1Academic Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, London, UK; 2East of England Deanery Vascular Surgery Training Programme, Cambridge, UK; 3Imperial Vascular Unit, Imperial College Healthcare NHS Trust, London, UK

Correspondence: Tristan RA Lane
Section of Vascular Surgery, Department of Surgery and Cancer, Imperial College London, 4N12A, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK
Email tristan.lane@imperial.ac.uk

Abstract: The American Venous Forum and the National Institute for Health and Care Excellence recommend endothermal ablation (ETA) techniques as the first line treatment for superficial venous incompetence. However, these techniques require the use of tumescent anaesthesia prior to energy delivery, which may be a source of discomfort for the patient and can prolong procedure time. Recently, nonthermal, nontumescent (NTNTs) techniques such as mechanochemical ablation (MOCA) have been developed to address some of the negative aspects associated with ETA. This article reviews this technique from a patient selection and perspective point view.

Keywords: endovenous ablation, varicose veins, venous disease, mechanochemical ablation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]